Fingerprint
Dive into the research topics of 'CX-072 (pacmilimab), a Probody ® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): An open-label dose-finding and first-in-human study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically